pyrrolidine dithiocarbamate has been researched along with Arteriovenous Malformations, Cerebral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, CZ; Xue, Z; Yang, GY; Young, WL; Zhu, Y | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and Arteriovenous Malformations, Cerebral
| Article | Year |
|---|---|
Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage.
Topics: Adenoviridae; Animals; Anti-Bacterial Agents; Antioxidants; Brain; Cerebral Hemorrhage; Disease Models, Animal; Humans; Intracranial Arteriovenous Malformations; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Minocycline; Pyrrolidines; Thiocarbamates; Vascular Endothelial Growth Factor A | 2007 |